Irritable bowel syndrome and Atherosclerosis


Atherosclerosis is found among people with Irritable bowel syndrome, especially for people who are female, 50-59 old.

The study analyzes which people have Atherosclerosis with Irritable bowel syndrome. It is created by eHealthMe based on reports of 17 people who have Irritable bowel syndrome from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2022

17 people who have Irritable Bowel Syndrome and Atherosclerosis are studied.

What is Irritable bowel syndrome?

Irritable bowel syndrome is found to be associated with 2,584 drugs and 1,980 conditions by eHealthMe.

What is Atherosclerosis?

Atherosclerosis (disorder of the arteries) is found to be associated with 2,126 drugs and 1,346 conditions by eHealthMe.

Number of Atherosclerosis in Irritable bowel syndrome reports submitted per year:

Would you have Atherosclerosis when you have Irritable bowel syndrome?

Gender of people who have Irritable Bowel Syndrome and experienced Atherosclerosis *:

  • female: 73.33 %
  • male: 26.67 %

Age of people who have Irritable Bowel Syndrome and experienced Atherosclerosis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 16.67 %
  • 30-39: 0.0 %
  • 40-49: 8.33 %
  • 50-59: 50.0 %
  • 60+: 25.0 %

Common co-existing conditions for these people *:

  1. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 23.53%
  2. Stress And Anxiety: 4 people, 23.53%
  3. Insomnia (sleeplessness): 4 people, 23.53%
  4. Osteoporosis (bones weak and more likely to break): 4 people, 23.53%
  5. Migraine (headache): 3 people, 17.65%
  6. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 17.65%
  7. Depression: 3 people, 17.65%
  8. Joint Pain: 3 people, 17.65%
  9. Acne (skin problems that cause pimples): 3 people, 17.65%
  10. Sinus Disorder (disease of sinus): 2 people, 11.76%

Common drugs taken by these people *:

  1. Lipitor: 10 people, 58.82%
  2. Prevacid: 5 people, 29.41%
  3. Paxil: 5 people, 29.41%
  4. Evista: 4 people, 23.53%
  5. Dicyclomine Hydrochloride: 4 people, 23.53%
  6. Zetia: 4 people, 23.53%
  7. Lescol Xl: 4 people, 23.53%
  8. Fosamax: 4 people, 23.53%
  9. Vytorin: 4 people, 23.53%
  10. Crestor: 4 people, 23.53%

Common symptoms for these people *:

  1. High Blood Pressure: 12 people, 70.59%
  2. Joint Pain: 9 people, 52.94%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 8 people, 47.06%
  4. Asthma: 8 people, 47.06%
  5. Breathing Difficulty: 7 people, 41.18%
  6. Depression: 7 people, 41.18%
  7. Infection: 7 people, 41.18%
  8. Gallstones (stone formation by bile component): 7 people, 41.18%
  9. Stress And Anxiety: 7 people, 41.18%
  10. Chest Pain: 6 people, 35.29%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Atherosclerosis?

Check whether Atherosclerosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Atherosclerosis:

Common drugs associated with Atherosclerosis:

All the drugs that are associated with Atherosclerosis:

Common conditions associated with Atherosclerosis:

All the conditions that are associated with Atherosclerosis:

How the study uses the data?

The study is based on Atherosclerosis and Irritable bowel syndrome, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: